Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
12/15/2004 | EP1485100A1 Azinylaminoazoles as inhibitors of protein kinases |
12/15/2004 | EP1485099A1 Inhibitors of histone deacetylase |
12/15/2004 | EP1485097A1 Crystalline forms of gatifloxacin and processes for preparation |
12/15/2004 | EP1485095A1 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
12/15/2004 | EP1485092A1 Use of rapamycin for inhibiting of cell death |
12/15/2004 | EP1485089A1 Combination treatments for chemokine-mediated diseases |
12/15/2004 | EP1485086A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane as nmda, 5ht3, and neuronal nicotinic receptor antagonists |
12/15/2004 | EP1485083A2 Dexanabinol and dexanabinol analogs regulate inflammation related genes |
12/15/2004 | EP1485079A2 Small molecule entry inhibitors |
12/15/2004 | EP1485064A2 Method for production of phytoalexins |
12/15/2004 | EP1485040A1 Method of administering an injectable antibiotic to the ear of an animal |
12/15/2004 | EP1484971A1 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces |
12/15/2004 | EP1414470A4 Micronutrient phosphates as dietary and health supplements |
12/15/2004 | EP1387840B1 3,5-diamino-1,2,4-triazoles as kinase inhibitors |
12/15/2004 | EP1383515B1 Activation of natural killer cells by adenosine a3 receptor agonists |
12/15/2004 | EP1322300B1 Inhalation particles incorporating a combination of two or more active ingredients |
12/15/2004 | EP1320533A4 Prodrugs of a 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotic |
12/15/2004 | EP1309594B1 Benzimidazole derivatives, preparation and therapeutic use thereof |
12/15/2004 | EP1294371B1 Medium chain fatty acids applicable as antimicrobial agents |
12/15/2004 | EP1284267B1 Triazole compounds having amide linkage |
12/15/2004 | EP1278742B1 Chromenylmethylpyrimidinediamines as antibacterial agents |
12/15/2004 | EP1226137B8 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
12/15/2004 | EP1212358B1 Synthetic papillomavirus genes optimized for expression in human cells |
12/15/2004 | EP1175222B1 Monthly doses of glycopeptide antibiotics for long-term prevention of streptococcus pneumoniae infections |
12/15/2004 | EP1149063B1 Ureido-thiobutyric acid derivatives as ppar-agonists |
12/15/2004 | EP1124545B1 Use of 2-methoxyestradiol as anti-fungal agents |
12/15/2004 | EP1091957B1 Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in the control of helicobacter bacteria |
12/15/2004 | EP1073461B1 Viral chimeras comprised of caev and hiv-1 genetic elements |
12/15/2004 | EP1068180B1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors |
12/15/2004 | EP1030547B1 Methods for preventing and treating bacterial infections using cellulose acetate phthalate or hydroxypropyl methylcellulose phthalate excipients |
12/15/2004 | EP1017283B1 Polynucleotide vaccine formulations |
12/15/2004 | EP0788507B1 L-pyranosyl nucleosides |
12/15/2004 | EP0630252B1 Pharmaceutical preparation based on rhamnolipid against dermatological diseases |
12/15/2004 | CN1555415A Synthetic HCV envelope proteins and their use for vaccination |
12/15/2004 | CN1555389A Oral-use polymer and oral-use composition |
12/15/2004 | CN1555385A Ligands to enhance cellular uptake of biomolecules |
12/15/2004 | CN1555379A Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
12/15/2004 | CN1555375A Compounds for inhibiting the release of inflammatory cytokines |
12/15/2004 | CN1555374A Novel pyridine-substituted pyrazolopyridine derivatives |
12/15/2004 | CN1555365A N-aminoimidazole derivative for inhibiting HIV |
12/15/2004 | CN1555357A Substituied ureaalkyl urea vitamin A protagonist ii |
12/15/2004 | CN1555351A Method for the preparation of unsaturated hydroxy fatty acids and their esters, their use in pharmaceutical and/or cosmetic preparations |
12/15/2004 | CN1555271A Interleukin-12 as a veterinary vaccine adjuvant |
12/15/2004 | CN1555270A Method for producing extracts of pelargonium sidoides and/or pelargonium reniforme, and the use of said extracts |
12/15/2004 | CN1555269A Exothermic formulations for the treatment of ectoparasites |
12/15/2004 | CN1555267A Method of treating middle ear infections |
12/15/2004 | CN1555266A Hormone replacement therapy |
12/15/2004 | CN1555264A Formulations for treatment of mucosal associated conditions with an immune response modifier |
12/15/2004 | CN1555262A Novel 4,5-dihydro-1H-pyrazole derivatives having CB*-antagonistic activity |
12/15/2004 | CN1555254A 免疫原性脂质体组合物 Immunogenic liposome composition |
12/15/2004 | CN1554764A Recombinant mva virus, and the use thereof |
12/15/2004 | CN1554664A Compounds and methods for diagnosis of tuberculosis |
12/15/2004 | CN1554647A Process for synthesizing ritonavir |
12/15/2004 | CN1554446A Carrier transferred adjuvant antigen and its preparing method |
12/15/2004 | CN1554445A Process for preparing recombined T4 phage oil emulsion vaccine and its use |
12/15/2004 | CN1554436A Veterinary medicine recipe capable of making multiple dosage form and dosago form making method |
12/15/2004 | CN1554432A Yinzhihuang injection preparation and its preparing method |
12/15/2004 | CN1554431A Restoring consciousness freezo-dried powder injection for injection and its preparing method |
12/15/2004 | CN1554420A New medicine for treating acute attack of tetanus |
12/15/2004 | CN1554402A Medicine for treating tinea peids |
12/15/2004 | CN1554392A Medicine for treating mycotic infection beriberi |
12/15/2004 | CN1554385A Antiseptic and its processing method |
12/15/2004 | CN1554384A Medicine for treating hepatitis B |
12/15/2004 | CN1554382A Medicine liqid for curing hepatopathy |
12/15/2004 | CN1554378A Medicinal paste for treating laryngopharyngitis, tonsillitis and infantile parotitis |
12/15/2004 | CN1554370A Medicine for treating virus hepatitis and its preparing method |
12/15/2004 | CN1554363A Anti-hepatitis b placenta specific factor extract with specific immunological activity and its preparing process |
12/15/2004 | CN1554362A Compound slow-release Anfennamin micro pill and preparing method |
12/15/2004 | CN1554357A Ribavirin oral drop pill and preparing process |
12/15/2004 | CN1554356A Method for preparing baicalin liquid |
12/15/2004 | CN1554355A Bite spiramycin and its use in anti inflammatory disease |
12/15/2004 | CN1554350A Nucleotide analog composition and synthesis method |
12/15/2004 | CN1554347A Therapeutic liquid for treating leuconychia |
12/15/2004 | CN1554345A Acicluvir gel preparation for eye and its preparing method |
12/15/2004 | CN1554339A Matrine enteric soluble hard capsule and its preparing method |
12/15/2004 | CN1554338A Sodium bisulfite andrographolide freeze drying preparation and its preparing method |
12/15/2004 | CN1554337A Medicinal composition having anti-biotic and anti-virus function |
12/15/2004 | CN1179970C Purine derivatives |
12/15/2004 | CN1179963C Cephalosporin kind antibiotics and composition and use |
12/15/2004 | CN1179960C Indole derivatives and their use for treamtent of osteoporosis amongst other applications |
12/15/2004 | CN1179951C Optical antimer of Saikexiaozuo and its preparing process and usage |
12/15/2004 | CN1179948C HIV protease inhibitors |
12/15/2004 | CN1179751C Foreign duck liver ichthyophthirius active vaccine and its preparation method |
12/15/2004 | CN1179750C Recombination alpha-interferon gelatin injection |
12/15/2004 | CN1179748C Stabilized pharmaceutical composition in lyophilized form |
12/15/2004 | CN1179735C Litholytic medicine for treating hepatolith and preparation process thereof |
12/15/2004 | CN1179732C Medicine for curing beriberi and running sore and boil and its preparing method |
12/15/2004 | CN1179726C Application of naringin in preapring medicine for supporting treatment of SARS |
12/15/2004 | CN1179724C Medicinal composition containing biphenyl lambral for treating superficial mycosis |
12/15/2004 | CN1179723C Application of geldanamycin in preparation of medicine for curing SARS |
12/15/2004 | CN1179646C Aggregation-preventing nano broad spectrum antibacterial silver powder and its inductrial production process |
12/14/2004 | US6831186 Antiinflammatory agents; autoimmune disease |
12/14/2004 | US6831177 Preparation of their intermediates, 2-acyl-5-benzylfuran derivatives and 1,2,4-triazole-3- carboxylic acid ester derivatives |
12/14/2004 | US6831096 Effective against both A and B forms of influenza; oral bioavailability |
12/14/2004 | US6831081 Herpes virus including simplex types 1 and 2, varicella zoster, human cytomegalovirus, Epstein-Barr and human 6, 7 and 8 |
12/14/2004 | US6831075 Heterocyclic substituted pyrazolones |
12/14/2004 | US6831070 Delivery of therapeutic gene products by intestinal cell expression |
12/14/2004 | US6831067 Substance having physiological property, method for producing the same and uses thereof |
12/14/2004 | US6831065 Anti-inflammatory compounds and uses thereof |
12/14/2004 | US6830748 Recombinant RSV virus expression systems and vaccines |